Company Presentation • 30 Jul 2026 18:00
Q1 2027
Company Presentation • 13 May 2026 18:00
Q4 2026
Company Presentation • 29 Mar 2026 08:30
Study Update
Company Presentation • 29 Jan 2026 18:30
Q3 2026
Company Presentation • 13 Jan 2026 09:15
𝛼SK or SearchENTITY
Takeda Pharmaceutical (4502 JP)
Takeda Pharmaceutical (4502 JP)
342
Analysis
Health Care • Japan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
morex